Edna od najupotrebu -va ni te irigatsii za ovaa namena e Sorbitol-Manitol irigatsijata.TsEL260Makedonski farmatsevtski bilten 57 (dodatok), 2011FARMATsEVTSKA TEKhNOLOGIJA I BIOFARMATsIJAposter prezentatsiiPETTI KONGRES NA FARMATsIJATA SO MEGjUNARODNO UChESTVONeredovnoto snabduvanje na nashiot pazar so IrigatsijataSorbitol-Manitol, koja e neopkhodna za TURP, navede napostavuvanje tsel: sozdavanje uslovi i otpochnuvanje so magistralnoproizvodstvo(proizvodstvo vo mal obem) na ovaa formulatsija, kakoi evaluatsija na kvalitetot i stabilnosta na proizvodot.METODISorbitol-Manitol Irigatsijata e sterilen, apirogen, khipotonichenvoden rastvor za uroloshka upotreba kako neelektrolitskairigatsija za vreme na transuretralnata khirurshka protsedura.100 ml rastvor sodrzi:2,70 g.sorbitol i 0,54 g.manitol vo voda zainektsii.Rastvorot e neelektrolitski i khipotonichen (178mOsmol/l), rN=5,2(4,0-7,0).Rastvorot ne sodrzhi bakteriostatitsi,antimikrobni sredstva i puferi i e namenet samo za ednokratnaupotreba.Dokolku ostanat mali portsii od preparatot ne smeat dase upotrebat za drug patsient tuku mora da se frlat.Minimum uslovi za magistralno proizvodstvo bea postignati:>> odgovorniot farmatsevt e so relevantno znaenje od oblasta iima praktichno i teoretsko iskustvo za proizvodstvo nasterilni preparati.>> site operatsii se izveduvaat od soodvetno treniran personal>> opremata e smestena vo prostorii koi onevozmozhuvaatkontaminatsija na preparatot>> sterilnoto proizvodstvo se odviva vo chisti prostorii>> standardni operativni protseduri se napishani i primenetiza opremata i protsesot na proizvodstvo>> vo prostoriite se odrzhuva khigienata soodvetno na pishanitei odobreni protseduriGlavnite chekori vo protsesot na proizvodstvo se:>> matematichki prorachuni>> farmatsevtska validatsija>> magistralna priprema>> signiranje>> skladishtenje>> distributsija>> vodenje dokumentatsijaREZULTATIFormulatsijata mora da bide pripremena vo Laminar-flo kabinet,upotrebuvajkji aseptichna postapka na izrabotka, kako ibakterioloshka filtratsija.Rastvorot se sterilizira soavtoklaviranje.Finalniot proizvod se kontrolira so soodvetnikontrolni postapki koi dokazhuvaat deka i vleznite surovini iprotsesnata analiza i gotoviot proizvod se so definiran kvalitet.Formulatsijata pokazha dobar kvalitet kako vo pogled na fizichkiteosobini, taka i vo pogled na fizichko-khemiskite i mikrobi olo sh ki -te parametri prema USP.Doziranata farmatsevtska forma e sta -bi lna edna godina od denot na proizvodstvo-uskladishtena prinashi uslovi.ZAKLUChOKBeshe mozhno da se prifati predizvikot i sozdadat uslovi za magi -stra lna priprema na formulatsijata:Sorbitol-Manitol Irigatsijaza transuretralna khirurshka interventsija vo Infuzionoto oddele -nie pri nashata Klinichka bolnitsaLITERATURA1.Handbook of Extemporaneous Preparation;A Guide to Pharmaceutical By Mark Jackson (Editor), Andrew Lowey (Editor)2.Pharmaceutical Compounding and DispensingJohn F., PhDMarriot (Autor);Keith A. PhDWilson (Autor)Christopher Andrew Langley(Autor);Daw Belcher (Autor)3.USP charperter <797>4.http/www.picscheme.org5.mhtml://H:/New folder/Teaching goals and learning objectives -BEAM 20106.Webber R(2006).Benign prostatic hyperplasia search date May 2005.Onlineversion of BMJ Clinical Evidence.ce.com.Also available online:http://www.clinicaleviden7. Fitzpatrick JM (2007). Minimally invasive and endoscopic management of benignprostatic hyperplasia. In AJ Wein, ed., Campbell-Walsh Urology, 9th ed., vol. 3. pp.2803-2844. Philadelphia: Saunders Elsevier8.Brookes ST, et al. (2002). Sexual dysfunction in men after treatment for lowerurinary tract symptoms: Evidence from randomised controlled study. BMJ,324(7345): 1059-1061.9. Paterson R, Goldenberg L (2001). Benign prostatic hyperplasia. In J Teichman,ed., 20 Common Problems in Urology, part 2, pp. 185-198. New York: McGraw-Hill.261Macedonian Pharmaceutical Bulletin 57 (suppl), 2011PHARMACEUTICAL TECHNOLOGY AND BIOPHARMACYposter presentationsFIFTH CONGRESS OF PHARMACY OF MACEDONIA WITH INTERNATIONAL PARTICIPATIONTOPICAL PREPARATIONS OF ALLICIN ANDALLICIN TRANSFORMERS: ANTIMICROBIALAND ANTI-IRRITATING EFFECTSVesna Savic1, Dusica Ilic2, Vesna Nikolic2, LjubisaNikolic2, Mihajlo Stankovic2, Ljiljana Stanojevic2,Marija Tasic-Kostov11Faculty of Medicine, Department of Pharmacy, Nis; 2Faculty of Technology, LeskovacINTRODUCTIONAllicin (diallyl thiosulfinate) is pharmacologically active component ofgarlic (Allium sativum L.). Farmacological effects of allicin aremanifested in: stroke [1], coronary thrombosis [1-3], hypertension [3,4],cancer [3]. Allicin is active against the most Gram-positive and Gram-negative bacteria [5-10]. Fungi such as Candida albicans andAspergillus niger are sensitive to allicin [5,10,11]. Allicin is unstableorganic molecule which is transformed to derivatives after application.Reaction depends from external factors. The best knownpharmacological active derivatives of allicin are ajoen [((E, Z) -4,5,9-thiododeca-1,6,11-trien-9-oxide)] and vinyldithiin compounds [2-vinyl-4H-1,3 - ditiin and 3-vinyl-4H-1 ,2-dithiin] [12]. Ajoens affect a largenumber of bacteria, viruses, fungi and parasites [7]. It is proven thatthey are the main inhibitors of platelet aggregation [13]. Vinilditiinesparticipate in the inhibition of platelet aggregation, inhibition ofcyclooxygenase and 5-lipoxygenase in the regulation of systolic anddiastolic blood pressure [14]. The aim of this study was to evaluate theantimicrobial and anti-irritating effects of the preparations withsynthesized Allicin and its transformers formulated in hydrogel basiswith Carbopol(r) Ultrez 10 polymer.METHODSAllicin was synthesized according to the procedure presented in theliterature [5]. Allicin transformation was carried out in methanol at550 degC under the effect of microwaves ("Discover" focus microwavereactor, CEM Corporation, Matthews, NC, USA). Hydrogel containingCarbopol(r) Ultrez 10 polymer (0.3%) with incorporated activeingredients (Allicin and Allicin transformers) was prepared. Anti-irritating activity was tested in vivo on artificially irritated skin. Non-invasive bioengineering method was used. In vivo testing wasperformed on six healthy male subjects. The artificial arm skinirritation was caused in four places by 50 ml of sodium lauryl sulfatesolution in the concentration of 12% using the method of occlusion[15]. The effect of placebo and gel with active substances (allicin orits transformers in the concentration of 0.3%) on irritated skin wasevaluated by biophysical parameters of the skin (skin hydratation,melanin index and erythema index) [16,17]. Subjective evaluation byexamining the participants using the evaluation erythema-visualanalog scale (VAS) was done [17]. Antimicrobial effects of topicalpreparation with Allicin and its transformers on bacteria:Staphylococus aureus ATCC 25923, Escherichia coli ATCC 25922,Pseudomonas aeruginosa ATCC 27853, ATCC 700603 Klebsielapneumoniae, Enterococus faecalis ATCC 29212, Salmonella enteritidisATCC 13076 and fungi: Candida albicans ATCC 10231, Aspergillusbrazilica ATCC 16404 was tested. Antimicrobial efficacy ofpreparations was tested by the membrane-free agar diffusion method.In vitro testing was performed on nutrient media: Mueller Hinton Agar(MHA-Oxoid) (for bacteria) (pH value after sterilization was 7.2) and forthe fungi Tryptone soy agar (Torlak Institute of Immunology andVirology, Belgrade) into Petri plates (8 cm in diameter).RESULTS AND DISCUSSIONAfter artificial irritation only in one patient all from the four treatedplaces were determined with value 2 by subjective evaluation on thevisual irritaton scale, which corresponds to moderate irritation.Preparation with the Allicin showed the highest rate of reduction themelanin index. The increasing in values of electrical capacity index asa measure of skin hydratation and decreasing in values of erythemaindex was the most obvious after the application of preparationscontaining Allicin transformers. That indicates that preparation withAllicin transformers has the greatest anti-irritating effect. Allicin andAllicin transformers incorporated in hydrogel basis were active againstall tested microorganisms.CONCLUSIONThe preparation containing Allicin was the most active againstStaphylococus aureus, and the preparation containing Allicintransformers was the most active against Escherichia coli.Pseudomonas aeruginosa was nearly resistant to both preparations.Also, the both preparations showed the strongest antifungal activityagainst Candida albicans. Hydrogel basis with Carbopol(r) Ultrez 10polymer do not reduce the antimicrobial and anti-irritating activity ofAllicin and its transformers and are suitable for making preparationsfor external use with the active substances which was tested in ourstudy.REFERENCES1. Block E., Ahmad S., Cataltamo J.L., Jain M.K., Apitz-Castro R., J. Am. Chem. Soc.108 (1986) 7045-7055.2. Fujisawa H., Suma K., K Origuchi., Kumagai H., Seki T., Ariga T., J. Agric. FoodChem. 56 (2008) 4229-4235.3. Lawson L.D., ACS Symposium Series, No 691. Washington, DC: AmericanChemical Society, (1998) 176-209.4. Miller K.L., Liebowitz R.S., Newby L.K, Am. Heart J. 147 (2004) 401-411.5. Nikolic V., Stankovic M., Nikolic Lj., Cvetkovic D., Pharmazie, 59 (2004) 10-14.6. Ilic D.P., Nikolic V.D., Nikolic Lj.B., Stankovic M.Z., Stanojevic Lj.P., Chem. Ind. 6(2010) 85-93.7. Amagase H., Petesch B.L., Matsuura H., Kasuga S., Itakura Y., Journal ofNutrition, 131 (2001) 955S-962S. 8. Ross Z.M., O'Gara E.A., Hill D.J., Sleightholme H.V., Maslin D.J, Applied andEnvironmental Microbiology, 67 (2001) 475-480. 9. Chen Yu-Ying, Chiu Hsein-Chung, Wang Yi-Bing, Journal of Food and DrugAnalysis, 17 (2009) 59-63. 10. Uchida Y., Takahashi T., Sato N., Japanese Journal of Antibiotics, 28 (1975) 638-642. Nikolic V., Stankovic M., Nikolic Lj., Cvetkovic D., Kapor A., Cakic M., ChemicalIndustry and Chemical Engineering Quarterly, 2 (2005) 69-73. 12. Sticher O., Dtsch. Apoth. Ztg. 131, (1991) 403-413. 13. Yamada N., Hattori A., Hayashi T., Nishikawa T., Fukuda H., Fujino T.,Pharmacology Biochemistry and Behavior, 78, (2004)787-791.14. Sanchez-Moreno C., Food Science and technology International 8, 3(2002)121-137.15. Fleming A.,et al :Anti-irritants II:efficacy against cumulative irritation,ContactDermatitis ,2006:55:155-159.16. Carrys P. et al:Skin color measurements, Skin Research andTechnology,6,2000.,230-238.17. Veber T.M. et al:Skin tolerance,efficacy,and quality of life patients with redfacial skin using a skin care regimen containing Licochalcone A,Journal of CosmeticDermatology2006,5,227-23218. Information and Operating Instruction for the Multi Probe AdapterMPA,CK,03/2008262Makedonski farmatsevtski bilten 57 (dodatok), 2011FARMATsEVTSKA TEKhNOLOGIJA I BIOFARMATsIJAposter prezentatsiiPETTI KONGRES NA FARMATsIJATA SO MEGjUNARODNO UChESTVOTHE MINERAL MUD IN DERMOCOSMETICPREPARATIONS IN TREATMENT OF ACNEPotpara Zorica 1,2, Jankovic Slobodan 31 Fontis Ltd., Podgorica, Montenegro2 Faculty of Pharmacy of the University of Montenegro3 Medical Faculty, University of Kragujevac, Kragujevac, SerbiaINTRODUCTIONOne of the most frequent skin diseases in adolescence is acne,affecting as much as 85% of that population. In spite of a variety ofestablished therapeutic approaches to treatment of acne vulgares, upto 12.7% of patients could not be cured. In order to overcomelimitations of the established therapy, botanicals and naturalpreparations of mineral origin are also used in therapy of acne. Theaim of our study was to investigate efficacy of topical therapy of acnewith preparation made by combination of peloid and medicinal plantsfrom Montenegro.METHODThe study was designed as retrospective cohort study, with twocohorts defined by the type of topical preparation used: one cohort (n= 70) comprised of the patients treated with Peloderm (topicalpreparation containing both peloid and medicinal plants' extracts),and another cohort (n = 70) of the patients treated by Antiacne(topical preparation with only medicinal plants' extracts). The patientsin both cohorts were treated for 18 months.RESULTSIn both treatment groups, the FDA acne severity score improvedgradually throughout the study visits. However, final FDA score (after18 months of topical treatment) was significantly (T = 7.556, df = 1, p= 0.000) lower in the Peloderm group (1.0 +- 0.0) than in the Anitiacnegroup (1.8+-0.9).CONCLUSIONBoth peloid and selected medicinal plants from Montenegro, preparedas topical preparations in ratios observed in this study, are efficientand safe options for local treatment of acne, the peloid havingsomewhat greater potency.REFERENCES1. Tan JKL. Current Measures for the Evaluation of Acne Severity. Expert RevDermatol 2008; 3: 595-603. 2. Stern RS. The prevalence of acne on the basis of physical examination. J AmAcad Dermatol 1992; 26: 931-935.3. Ayer J, Burrows N. Acne: more than skin deep. Postgrad Med J 2006; 82: 500-6. 4. Sardana K, Garg VK, Sehgal VN, Mahajan S, Bhushan P. Efficacy of fixed low-doseisotretinoin (20 mg, alternate days) with topical clindamycin gel in moderatelysevere acne vulgaris. J Eur Acad Dermatol Venereol 2009; 23: 556-60.5. Shaughnessy KK, Bouchard SM, Mohr MR, Herre JM, Salkey KS.